BMPR2 and pulmonary arterial hypertension: Recently published studies on the molecular pathology of PAH have yielded novel data on mutations in genes associated with bone morphogenetic protein receptor type 2 (BMPR2), the role of growth factors, inflammation, hypoxia, and metabolic remodeling [2,3,4,5].